Caledonia Investments

Caledonia Investments is a UK-based self-managed investment trust and a constituent of the FTSE 250 Index, with a significant focus on the healthcare and life sciences sectors through its Private Capital division. The firm operates as a long-term investor, managing a concentrated portfolio of international quoted investments, private companies, and specialist funds. In the healthcare space, Caledonia has a track record of backing established businesses, notably including BioAgilytix, a global leader in large molecule bioanalysis for the pharmaceutical industry, and Durbin, a specialist distributor of pharmaceuticals. The company seeks to provide long-term capital growth and dividend income by partnering with strong management teams in defensive, high-growth sectors. Headquartered in London, Caledonia is majority-owned by the Cayzer family and maintains a patient, long-term investment horizon.